| Literature DB >> 22962342 |
Jean-Baptiste Cazier1, Chris C Holmes, John Broxholme.
Abstract
SUMMARY: GREVE has been developed to assist with the identification of recurrent genomic aberrations across cancer samples. The exact characterization of such aberrations remains a challenge despite the availability of increasing amount of data, from SNParray to next-generation sequencing. Furthermore, genomic aberrations in cancer are especially difficult to handle because they are, by nature, unique to the patients. However, their recurrence in specific regions of the genome has been shown to reflect their relevance in the development of tumors. GREVE makes use of previously characterized events to identify such regions and focus any further analysis. AVAILABILITY: GREVE is available through a web interface and open-source application (http://www.well.ox.ac.uk/GREVE).Entities:
Mesh:
Year: 2012 PMID: 22962342 PMCID: PMC3496338 DOI: 10.1093/bioinformatics/bts547
Source DB: PubMed Journal: Bioinformatics ISSN: 1367-4803 Impact factor: 6.937
Fig. 1.Usage of GREVE where (a) pre-processing from any source generates a list of events to be used as (b) input together with the optional DGV, Configuration and Gene file. This can generate several output (c): two types of genome-wide views (sorted by aberration type or individual), chromosome view with overlap, gene and labels, as well as the detailed list of overlapping events with corresponding counts and statistics